ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
10.15
-0.15 (-1.46%)
Feb 3, 2026, 4:00 PM EST - Market closed
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1 billion as of February 4, 2026. Its market cap has decreased by -17.87% in one year.
Market Cap
1.00B
Enterprise Value
884.91M
1-Year Change
-17.87%
Ranking
Category
Stock Price
$10.15
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.00B, an increase of 76.56%. That is a compound annual growth rate of 19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.00B | -12.88% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.07B |
| AbCellera Biologics | 1.05B |
| Iovance Biotherapeutics | 1.04B |
| CytomX Therapeutics | 1.03B |
| Nanobiotix | 1.02B |
| Theravance Biopharma | 1.00B |
| Ventyx Biosciences | 1.00B |
| Geron | 983.07M |